NFE2 anticorps (AA 20-373) (PE)
Aperçu rapide pour NFE2 anticorps (AA 20-373) (PE) (ABIN8016339)
Antigène
Voir toutes NFE2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 20-373
-
Fonction
- Anti-NFE2 Antibody PE Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- E.coli-derived human NFE2 recombinant protein (Position: E20-D373).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- NFE2 (Nuclear Factor (Erythroid-Derived 2), 45kDa (NFE2))
-
Autre désignation
- NFE2
-
Sujet
-
Background: Transcription factor NF-E2 45 kDa subunit is a protein that in humans is encoded by the NFE2 gene. Enables several functions, including WW domain binding activity, identical protein binding activity, and protein N-terminus binding activity. Contributes to cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including labyrinthine layer blood vessel development, negative regulation of bone mineralization, and negative regulation of syncytium formation by plasma membrane fusion. Part of protein-DNA complex.
Gene Full Name: nuclear factor, erythroid 2
-
ID gène
- 4778
-
UniProt
- Q16621
Antigène
-